ClinVar Miner

Submissions for variant NM_001540.5(HSPB1):c.372C>G (p.His124Gln)

gnomAD frequency: 0.00003  dbSNP: rs145243219
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000558321 SCV000640212 likely pathogenic Charcot-Marie-Tooth disease axonal type 2F 2024-11-15 criteria provided, single submitter clinical testing This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 124 of the HSPB1 protein (p.His124Gln). This variant is present in population databases (rs145243219, gnomAD 0.01%). This missense change has been observed in individuals with clinical features of autosomal dominant Charcot-Marie-Tooth disease and/or distal hereditary motor neuropathy (PMID: 32376792; internal data). ClinVar contains an entry for this variant (Variation ID: 465273). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on HSPB1 protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Athena Diagnostics RCV000711974 SCV000842385 uncertain significance not provided 2018-01-25 criteria provided, single submitter clinical testing
Molecular Genetics Laboratory, London Health Sciences Centre RCV001172546 SCV001335607 uncertain significance Charcot-Marie-Tooth disease criteria provided, single submitter clinical testing
GeneDx RCV000711974 SCV001820623 uncertain significance not provided 2022-02-09 criteria provided, single submitter clinical testing Reported as a variant of uncertain significance in two patients with Charcot-Marie-Tooth disease in published literature (Volodarsky et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32376792)
CeGaT Center for Human Genetics Tuebingen RCV000711974 SCV002563956 uncertain significance not provided 2022-07-01 criteria provided, single submitter clinical testing HSPB1: PM1, PP3, PP4
MGZ Medical Genetics Center RCV000558321 SCV002579513 uncertain significance Charcot-Marie-Tooth disease axonal type 2F 2022-03-21 criteria provided, single submitter clinical testing
Ambry Genetics RCV002350273 SCV002620345 likely benign Inborn genetic diseases 2021-08-18 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.